SUMMARY We here describe a case of presumed Mycoplasma pneumoniae endocarditis complicating rheumatic aortic valvular disease. We do not know of any previously reported cases.
Since its identification by Chanock et al.1 Mycoplasma pneumoniae (M. pneumoniae) has emerged as an important cause of upper and lower respiratory tract infections in man. However, this organism has been associated very rarely with disease of the cardiovascular system.2 We report a case of presumed M. pneumoniae endocarditis in a patient with rheumatic heart disease; though pericarditis and myocarditis have been previously described, there are no reported cases of M. pneumoniae endocarditis.
Case reports
A 21-year-old Lebanese student was admitted with a four days' history of general malaise, lethargy, sore throat, and anorexia. He gave a past history of acute rheumatic fever with pancarditis in 1972 while in Kuwait. Four weeks before admission he had undergone dental extraction without approppriate antibiotic cover, though over the previous six years he had intermittently received long-acting benzyl-penicillin (Penidural) intramuscularly as prophylaxis against rheumatic fever. In addition, he had given himself opium intravenously on several occasions in the months before this illness.
Physical Popat, Barnardo, Webb-Peploe While awaiting results of blood culture and antibody titres intravenous treatment with 12 mega units of benzyl penicillin and gentamicin 240 mg daily was started and continued for six weeks. This was later followed by a four-week course of oxytetracycline. Considerable improvement followed the start of antibiotic treatment and the pyrexia subsided. However, aortic regurgitation worsened, and three months after presentation the patient underwent aortic valve replacement (with Carpentier Edwards xenograft). At operation, the aortic valve was found to be thickened and fibrotic, the aortic valve ring was dilated, and the aortic wall appeared normal. Microscopy of the valve cusp revealed organising thrombotic vegetations, though no micro-organisms were seen.
Discussion
Finkelstein and Klainer3 were the first authors to describe the possible association of M. pneumoniae infection with cardiovascular disease, reporting three cases of pericarditis associated with clinical features of "atypical pneumonia". Since then, there have been a few single case reports of cardiovascular involvement with complications of pericarditis and perimyocarditis.4 5 The largest survey was that of Sands et al.6 who described, between 1970 and 1973, eight patients with acute pericarditis and five with perimyocarditis associated with M. pneumoniae infection.
Rising antibody titres against M. pneumoniae and the presence of specific IgM antibody provided strong evidence for a recent mycoplasma infection in our patient. That he also had active infective endocarditis was suggested by microscopical haematuria, the tender enlarged spleen, and the rapid disintegration of his aortic valve with vegetations seen on valve histology. The methods of routine blood culture used on his admission to hospital would not have grown the organism and subsequently the patient was given gentamicin followed by oxytetracycline, thereby negating special culture techniques, as gentamicin has recently been shown to be highly effective against mycoplasma species.
As a result of our experience, we therefore suggest that M. pneumoniae should be borne in mind as a possible source of infection when considering the cause of atypical infective endocarditis.
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